sp_news grid="3"
November 4, 2018
Case Western Reserve Embarks on Innovative Path to Treat Infections of Drug-Resistant Superbugs such as MRSA without Antibiotics
School of Medicine’s biochemistry department team, in partnership with Q2 Pharma, to develop antivirulence agents that disarm bacteria of deadly...
Read More
sp_news
4
Nov 18
Case Western Reserve Embarks on Innovative Path to Treat Infections of Drug-Resistant Superbugs such as MRSA without Antibiotics
School of Medicine’s biochemistry department team, in partnership with Q2 Pharma, to develop antivirulence agents that disarm bacteria of deadly...
Read More
